[HTML][HTML] Cathepsin L is essential for onset of autoimmune diabetes in NOD mice

R Maehr, JD Mintern, AE Herman… - The Journal of …, 2005 - Am Soc Clin Investig
R Maehr, JD Mintern, AE Herman, AM Lennon-Duménil, D Mathis, C Benoist, HL Ploegh
The Journal of clinical investigation, 2005Am Soc Clin Investig
Lysosomal proteases generate peptides presented by class II MHC molecules to CD4+ T
cells. To determine whether specific lysosomal proteases might influence the outcome of a
CD4+ T cell–dependent autoimmune response, we generated mice that lack cathepsin L
(Cat L) on the autoimmune diabetes-prone NOD inbred background. The absence of Cat L
affords strong protection from disease at the stage of pancreatic infiltration. The numbers of
IA g7–restricted CD4+ T cells are diminished in Cat L–deficient mice, although a potentially …
Lysosomal proteases generate peptides presented by class II MHC molecules to CD4+ T cells. To determine whether specific lysosomal proteases might influence the outcome of a CD4+ T cell–dependent autoimmune response, we generated mice that lack cathepsin L (Cat L) on the autoimmune diabetes-prone NOD inbred background. The absence of Cat L affords strong protection from disease at the stage of pancreatic infiltration. The numbers of IA g7–restricted CD4+ T cells are diminished in Cat L–deficient mice, although a potentially diabetogenic T cell repertoire persists. Within the CD4+ T cell compartments of Cat L–deficient mice, there is an increased proportion of regulatory T cells compared with that in Cat L–sufficient littermates. We suggest that it is this displaced balance of regulatory versus aggressive CD4+ T cells that protects Cat L–deficient mice from autoimmune disease. Our results identify Cat L as an enzyme whose activity is essential for the development of type I diabetes in the NOD mouse.
The Journal of Clinical Investigation